About ELEM Biotech
ELEM Biotech is a healthcare technology company specializing in cardiac digital twin platforms that transform drug development and clinical decision-making. The company's flagship products, V.HEART Trials and V.HEART Discovery, enable pharmaceutical companies, clinical research organizations, medical device manufacturers, and healthcare providers to simulate virtual clinical trials and predict cardiac safety risks before human testing. V.HEART Discovery focuses on early-stage cardiac safety prediction, allowing researchers to screen drug candidates for QT prolongation and arrhythmic risk across concentration ranges up to 50x effective doses. V.HEART Trials enables full clinical trial simulation on the cloud, allowing users to configure virtual patient populations, apply treatments, and analyze results in hours rather than months. The technology combines patient-specific data, high-performance physics-based simulation, and advanced AI to create virtual human populations that reflect real-world diversity. ELEM's platforms help clients reduce R&D costs by up to 80%, decrease failure rates by 30%, and generate scientific evidence for regulatory submissions. The company serves multiple healthcare sectors including pharma, CROs, regulators, medical device companies, and health delivery organizations, supporting applications from hit-to-lead optimization to precision medicine and value-based healthcare initiatives.
Clinical Focus
Medical conditions and clinical areas addressed by ELEM Biotech.
Who It Serves
Milestones & Awards
Recent Milestones
Published AI-enhanced cardiac digital twins paper on drug proarrhythmic risk assessment. Conducted cardio-oncology safety trial with 120 virtual patients. Completed pacing optimization study using 15 real patient digital twins expanded to 150 synthetic patients. Developed respiratory drug delivery optimization for 5,000 virtual population from 100 anatomies.
Key Partnerships
Social & Media
Latest Updates
Company Details
- Headquarters
- Barcelona, Catalonia, Spain
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.